Novo Holdings A/S as of June 30, 2024
Portfolio Holdings for Novo Holdings A/S
Novo Holdings A/S holds 38 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vanguard Index Fds Total Stk Mkt (VTI) | 15.0 | $278M | 1.0M | 267.51 | |
| Brookfield Corp Cl A Ltd Vt Sh (BN) | 8.7 | $161M | 3.9M | 41.54 | |
| Tempus Ai Cl A (TEM) | 7.7 | $143M | 4.1M | 35.00 | |
| Asml Holding N V N Y Registry Shs (ASML) | 7.4 | $136M | 133k | 1022.73 | |
| salesforce (CRM) | 6.7 | $123M | 480k | 257.10 | |
| Edgewise Therapeutics (EWTX) | 6.2 | $114M | 6.3M | 18.01 | |
| Corcept Therapeutics Incorporated (CORT) | 4.2 | $78M | 2.4M | 32.49 | |
| Vaxcyte (PCVX) | 3.9 | $72M | 950k | 75.51 | |
| Insmed Com Par $.01 (INSM) | 2.9 | $54M | 800k | 67.00 | |
| Mirum Pharmaceuticals (MIRM) | 2.8 | $51M | 1.5M | 34.19 | |
| Crinetics Pharmaceuticals In (CRNX) | 2.4 | $45M | 1.0M | 44.79 | |
| Cable One (CABO) | 2.3 | $42M | 118k | 354.00 | |
| BioMarin Pharmaceutical (BMRN) | 2.2 | $40M | 490k | 82.33 | |
| Merus N V (MRUS) | 2.2 | $40M | 675k | 59.17 | |
| Apple (AAPL) | 2.1 | $39M | 183k | 210.62 | |
| Alibaba Group Hldg Sponsored Ads (BABA) | 1.9 | $36M | 501k | 72.00 | |
| Pharvaris N V (PHVS) | 1.7 | $32M | 1.7M | 18.80 | |
| Celldex Therapeutics Com New (CLDX) | 1.7 | $32M | 850k | 37.01 | |
| 4d Molecular Therapeutics In (FDMT) | 1.6 | $29M | 1.4M | 20.99 | |
| Lanzatech Global (LNZA) | 1.6 | $29M | 16M | 1.85 | |
| Alnylam Pharmaceuticals (ALNY) | 1.6 | $29M | 118k | 243.00 | |
| Arrivent Biopharma (AVBP) | 1.5 | $28M | 1.5M | 18.55 | |
| Miragen Therapeutics (VRDN) | 1.4 | $26M | 2.0M | 13.01 | |
| Cargo Therapeutics (CRGX) | 1.4 | $25M | 1.5M | 16.42 | |
| Amicus Therapeutics (FOLD) | 1.3 | $25M | 2.5M | 9.92 | |
| Brookfield Asset Managmt Cl A Lmt Vtg Shs (BAM) | 1.3 | $24M | 627k | 38.05 | |
| Rocket Pharmaceuticals (RCKT) | 1.3 | $24M | 1.1M | 21.53 | |
| Lexeo Therapeutics (LXEO) | 1.3 | $23M | 1.5M | 16.04 | |
| Blueprint Medicines (BPMC) | 1.0 | $19M | 175k | 107.78 | |
| Kyverna Therapeutics (KYTX) | 0.7 | $13M | 1.8M | 7.50 | |
| Morphic Hldg (MORF) | 0.7 | $13M | 375k | 34.07 | |
| Verve Therapeutics (VERV) | 0.6 | $12M | 2.4M | 4.88 | |
| Metagenomi (MGX) | 0.4 | $7.3M | 1.8M | 4.08 | |
| Io Biotech (IOBT) | 0.3 | $5.2M | 4.4M | 1.17 | |
| Abcellera Biologics (ABCL) | 0.2 | $3.3M | 1.1M | 2.96 | |
| Marqeta Class A Com (MQ) | 0.1 | $2.4M | 442k | 5.48 | |
| Galecto (GLTO) | 0.1 | $1.2M | 2.5M | 0.47 | |
| Spero Therapeutics (SPRO) | 0.0 | $610k | 469k | 1.30 |
